|
GABPB1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.558800E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.239300E-03 |
| Normal-vs-Stage2 |
8.358900E-04 |
| Normal-vs-Stage3 |
4.11160000000077E-05 |
| Normal-vs-Stage4 |
7.68669999984262E-07 |
| Stage1-vs-Stage2 |
9.582000E-02 |
| Stage1-vs-Stage3 |
1.246330E-02 |
| Stage1-vs-Stage4 |
3.218100E-04 |
| Stage2-vs-Stage3 |
8.674200E-01 |
| Stage2-vs-Stage4 |
2.952000E-01 |
| Stage3-vs-Stage4 |
2.713000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.365900E-04 |
| Normal-vs-AfricanAmerican |
6.544000E-02 |
| Normal-vs-Asian |
1.757510E-02 |
| Caucasian-vs-AfricanAmerican |
5.795000E-01 |
| Caucasian-vs-Asian |
5.941000E-01 |
| AfricanAmerican-vs-Asian |
8.912200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.358000E-04 |
| Normal-vs-Female |
2.354500E-04 |
| Male-vs-Female |
7.447200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.578000E-02 |
| Normal-vs-Age(41-60Yrs) |
2.0028999999977E-05 |
| Normal-vs-Age(61-80Yrs) |
2.26410000003785E-06 |
| Normal-vs-Age(81-100Yrs) |
1.495230E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.057900E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.198200E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.251800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.927200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.128800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.952000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.716300E-02 |
| Classical-VS-Follicular |
6.995700E-03 |
| Classical-VS-Other |
3.051800E-01 |
| Classical-VS-Normal |
4.437800E-03 |
| Tall-VS-Follicular |
9.002600E-01 |
| Tall-VS-Other |
9.409600E-01 |
| Tall-VS-Normal |
1.215690E-03 |
| Follicular-VS-Other |
9.990000E-01 |
| Follicular-VS-Normal |
7.60990000000517E-05 |
| Other-VS-Normal |
5.397600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.09190000000081E-05 |
| Normal-vs-N1 |
2.960000E-04 |
| N0-vs-N1 |
7.170000E-01 |
|
|
